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The dopamine mesocorticoaccumbens pathway which originates in the ventral tegmental
area (VTA) and projects to the nucleus accumbens and prefrontal cortex is a circuit impor-
tant in mediating the actions of psychostimulants.The function of this circuit is modulated
by the actions of serotonin (5-HT) at 5-HT2A receptors (5-HT2AR) localized to the VTA. In the
present study, we tested the hypothesis that virally mediated overexpression of 5-HT2AR in
the VTA would increase cocaine-evoked locomotor activity in the absence of alterations in
basal locomotor activity. A plasmid containing the gene for the 5-HT2AR linked to a synthetic
marker peptide (Flag) was created and the construct was packaged in an adeno-associated
virus vector (rAAV-5-HT2AR-Flag). This viral vector (2µl; 109–10 transducing units/ml) was
unilaterally infused into the VTA of male rats, while control animals received an intra-VTA
infusion of Ringer’s solution.Virus-pretreated rats exhibited normal spontaneous locomotor
activity measured in a modified open-field apparatus at 7, 14, and 21 days following infu-
sion. After an injection of cocaine (15 mg/kg, ip), both horizontal hyperactivity and rearing
were significantly enhanced in virus-treated rats (p<0.05). Immunohistochemical analy-
sis confirmed expression of Flag and overexpression of the 5-HT2AR protein. These data
indicate that the vulnerability of adult male rats to hyperactivity induced by cocaine is
enhanced following increased levels of expression of the 5-HT2AR in the VTA and sug-
gest that the 5-HT2AR receptor in the VTA plays a role in regulation of responsiveness
to cocaine.
Keywords: 5-HT2A receptor, cocaine, serotonin, virally mediated gene transfer, AAV, ventral tegmental area,
locomotor activity, psychostimulants
INTRODUCTION
Cocaine addiction is marked by significant morbidity and loss of
human potential, yet consistently effective and accessible recov-
ery options remain limited. This fact underscores the continuing
need to uncover the neural factors that drive vulnerability to
cocaine addiction and relapse and to establish new pharmaco-
logical strategies to halt or reverse the progression of the disorder.
Cocaine inhibits reuptake of monoamines, including dopamine
(DA) and serotonin (5-hydroxytryptamine; 5-HT; Koe, 1976) and
the enhanced efflux of DA within the mesocorticoaccumbens cir-
cuit is critical in the generation of cocaine-evoked behaviors (Kelly
and Iversen, 1976; Delfs et al., 1990; Callahan et al., 1994). The
mesocorticoaccumbens DA neurons, which originate in the ven-
tral tegmental area (VTA) and project prominently to subcortical
[e.g., nucleus accumbens (NAc)] and cortical structures [e.g., pre-
frontal cortex (PFC)], are under the modulatory control of the
5-HT system (Alex and Pehek, 2007), with 5-HT neurons in the
dorsal raphe nucleus innervating both cell body and terminal
regions of the mesocorticoaccumbens circuit (Halliday and Tork,
1989). As such, the 5-HT system is also an important mediator of
cocaine-evoked behaviors (for reviews, see Walsh and Cunning-
ham, 1997; Muller and Huston, 2006; Bubar and Cunningham,
2008; Filip et al., 2010).
The 5-HT2A receptor (5-HT2AR), one of 14 subtypes of 5-HT
receptors (Hoyer et al., 2002), plays an integral role in mediating
the serotonergic influence upon cocaine-evoked behaviors (Muller
and Huston, 2006; Bubar and Cunningham, 2008). Blockade of the
5-HT2AR with a selective antagonist (e.g., M100907; SR46349B)
significantly reduces cocaine-evoked hypermotility (O’Neill et al.,
1999; McMahon and Cunningham, 2001; Fletcher et al., 2002; Filip
et al., 2004; Szucs et al., 2005), behavioral sensitization (Filip et al.,
2004; Zayara et al., 2011), and behavioral disinhibition (Anasta-
sio et al., 2011; Fletcher et al., 2011; Cunningham et al., 2013), as
well as the discriminative stimulus effects of cocaine (Filip et al.,
2006) and cocaine- (Fletcher et al., 2002) and cue-primed (Nic
Dhonnchadha et al., 2009; Pockros et al., 2011) reinstatement
of cocaine-seeking in rats. Systemic administration of the non-
selective 5-HT2AR antagonist ketanserin inhibited cocaine-evoked
hypermotility simultaneous with inhibition of cocaine-evoked DA
release in the NAc (Broderick et al., 2004), suggesting an important
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role for 5-HT2AR-modulation of DA mesocorticoaccumbens neu-
rotransmission in cocaine-evoked behaviors mediated by this
circuit.
The 5-HT2AR is a G protein-coupled receptor (Berg et al., 1994)
expressed throughout the nodes of the mesocorticoaccumbens cir-
cuit (Cornea-Hebert et al., 1999; Doherty and Pickel, 2000; Xu and
Pandey, 2000; Nocjar et al., 2002; Miner et al., 2003). The 5-HT2AR
resident in the VTA is localized to both DA and non-DAergic [pre-
sumably γ-aminobutyric (GABA) or glutamate] neurons within
the VTA (Doherty and Pickel, 2000; Nocjar et al., 2002), and appear
to be integral in modulating psychostimulant-induced behaviors
mediated by the mesocorticoaccumbens circuit. Microinfusion of
the selective 5-HT2AR antagonist M100907 into the VTA, but not
the NAc, attenuated hyperactivity evoked by systemic administra-
tion of cocaine at doses that did not alter basal motor activation
(McMahon et al., 2001). Likewise, intra-VTA 5-HT2AR antagonist
administration significantly blocked amphetamine-evoked hyper-
activity and associated DA release in the NAc, with no effect upon
basal motor activity or DA efflux in NAc (Auclair et al., 2004).
We have observed that microinfusion of the preferential 5-HT2AR
agonist 1-(2,5-dimethoxy-4-iodo)-2-aminopropane (DOI) alone
into the VTA is sufficient to evoke hyperactivity in rats (Herin et
al., unpublished observations). Thus, activation of 5-HT2AR resi-
dent in the VTA results in behaviorally significant outcomes, and
likewise appears to play a critical role in cocaine-evoked behaviors
mediated by the DA mesocorticoaccumbens circuit.
The virally mediated gene transfer technique represents a tar-
geted means to manipulate the expression of important proteins
in the brains of adult animals (Carlezon et al., 1997; Bolanos
et al., 2003; Edry et al., 2011). A recombinant adeno-associated
virus (rAAV) can be used to selectively transduce neurons for
a long duration (weeks to months) with a minimum of toxic-
ity and inflammation (McCown et al., 1996; Lo et al., 1999). In
the present study, we have exploited rAAV-mediated gene trans-
fer to investigate whether overexpression of the 5-HT2AR in the
VTA alters the vulnerability of adult male rats to the hypermo-
tive effects of cocaine. We developed an rAAV containing the
coding region for the 5-HT2AR linked to a synthetic marker
peptide (Flag; rAAV-5-HT2AR-Flag), and infused vehicle or rAAV-
5-HT2AR-Flag unilaterally into the VTA of experimental animals,
followed by measurement of basal and cocaine-evoked hyperactiv-
ity. Immunohistochemical analyses were used to confirm 5-HT2AR
overexpression as well as expression of the Flag peptide.
MATERIALS AND METHODS
ANIMALS
Male Sprague-Dawley rats (Harlan Sprague-Dawley, Inc., Indi-
anapolis, IN, USA) weighed 250–275 g at the beginning of the
study. The rats were housed (initially four/cage) in standard plastic
rodent cages in a temperature (21–23˚C) and humidity (55–65%)
controlled environment under a 12-h light/dark cycle (lights on
07:00 h). Animals were acclimated to the colony for 3–5 days prior
to surgery, after which they were single-housed and allowed to
recover for at least one week prior to the start of experimental
sessions. All animals were provided with food and water ad libi-
tum. Experiments were conducted during the light phase of the
light-dark cycle (1200–1800 h) and were in accordance with the
National Institutes of Health Guide for the Care and Use of Lab-
oratory Animals and with approval from the UTMB Institutional
Animal Care and Use Committee.
VIRAL VECTORS
The cDNA containing the coding region for the rat 5-HT2AR
was obtained (Dr. J. Liu, University of Cincinnati). Primers were
designed to amplify only the coding region of the 5-HT2AR and to
add a BamHI site (to the 5′ end), SpeI site (to the 3′ end), 24 bases
coding for a synthetic marker (Flag) protein and a stop codon.
PCR amplification was performed using an rTtH-XL polymerase
(Perkin Elmer, Boston, MA, USA) and the product (5-HT2AR-
Flag) was purified by preparative agarose gel electrophoresis fol-
lowed by dialysis, phenol/chloroform/isoamyl alcohol (25:24:1)
extraction and ethanol precipitation.
The 5-HT2AR-Flag DNA was then ligated into a pCW plasmid,
which is appropriate for viral packaging. The pCW plasmid (pro-
vided by Dr. D. J. Poulsen; University of Montana) contains the
inverted terminal repeats (ITR) of AAV, a chick β-actin (CAG)
promoter, multiple cloning sites, and a woodchuck hepatitis virus
posttranscriptional regulatory element (WPRE; Stone et al., 2005).
5-HT2AR-Flag (300 fmol) and pCW (30 fmol) were digested with
BamHI (2 units) and SpeI (5 units) for 2 h at 37˚C. Ligation was
performed with a kit (TaKaRa Biochemical, Inc., Berkeley, CA,
USA). Ten microliters of the resultant cDNA was used to transform
DH5-α ultracompetent E. coli containing 50µg/ml ampicillin.
Plasmid DNA was isolated from 20 colonies and tested for inclu-
sion of the plasmid by digestion with BamHI and SpeI. One
positive colony was CsCl-purified and sequenced at the UTMB
Molecular Biology Core Facility. Functionality of the transgene
was determined by transfection in raphe RN46A cells (provided
by Dr. Scott Whittemore, University of Miami; White et al., 1994)
followed by immunocytochemical detection with 5-HT2AR and
Flag antibodies.
The rAAV-5-HT2AR-Flag was prepared by cotransfecting three
plasmids into human embryonic kidney cells (HEK 293 cell line)
based on previous protocols (Xiao et al., 1998; Wu et al., 2002)
utilizing an AAV helper plasmid (pXX2) and an adenovirus helper
plasmid (pXX6). The HEK cells were cultured in 150 mm dishes
containing DMEM/10% FBS at 37˚C, 5% CO2. When cells reached
80% confluence, calcium phosphate precipitation was used for co-
transfection with pCW-5-HT2AR-Flag, pXX2, and pXX6. Follow-
ing a brief rinse with DMEM, OptiMEM (Life Technologies)/10%
FBS/120µM chloroquine was added to the cells. Then 2.5 ml
of DNA–calcium phosphate solution was added per plate. This
solution contained three plasmids at the molar ratio of 7:2:4,
125 mM CaCl2 and 1× HBS (2.5 M NaCl, 0.25 M HEPES, 75 mM
Na2HPO4, pH 7.1). Cells were cultured with 5% CO2 at 37˚C
for 18 h, and changed with OptiMEM/10% FBS. Two days after
co-transfection, cells and medium were collected, centrifuged at
1140 g for 15 min, and then resuspended in 150 mM NaCl/20 mM
Tris pH 8.0 at 5× 106 cells/ml. The cell suspension was further
treated with 0.54% deoxycholate (Sigma, St. Louis, MO, USA) and
50 U/ml Benxonase (Sigma) at 37˚C for 1 h. Following centrifu-
gation at 3000 g at room temperature for 20 min, supernatants
were subjected to a cycle of freeze − thaw, and then centrifuged
again at 10,000 g at 4˚C for 30 min. The supernatant was collected,
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filtered through a 1-µm disk filter (Fisher, Pittsburgh, PA, USA),
and then run by gravity through a heparin agarose type I col-
umn (Sigma) pre-equilibrated with phosphate buffer saline/1 mM
MgCl2/2.5 mM KCl phosphate-buffered saline (PBS-MK). After
four washes with 5 ml PBS-MK each, rAAV viruses were eluted by
9 ml of 1 M NaCl/PBS-MK. The first 2 ml was discarded. The next
7 ml was collected, desalted by running through a Centricon Plus-
20/Biomax-100 (Fisher) with four changes of lactated Ringer’s
solution, then concentrated by centrifugation at 3000 g at room
temperature, and the elution was collected. Dot blot indicated
that the titer of the packaged virus was in the range of 109–1010
transducing units/ml.
ANIMAL SURGERY
Rats (n= 10/group) were anesthetized intramuscularly (IM) with
43 mg/kg of ketamine, 8.6 mg/kg of xylazine, and 1.5 mg/kg of
acepromazine in physiological saline (0.9% NaCl) and placed in a
Kopf rat stereotaxic apparatus (David Kopf Instruments, Tujunga,
CA, USA) with the upper incisor bar at −3.8 mm below the
interaural line. A Hamilton microsyringe (Hamilton, Reno, NV,
USA) was then lowered unilaterally into the VTA at a 9˚ from
the midsaggital plane in relation to bregma: [anteroposterior (AP)
−5.3 mm, mediolateral (ML)+ 1.3 mm, and dorsoventral (DV)
−8.1 and 8.5 mm from skull (Paxinos and Watson, 1998; McMa-
hon et al., 2001; Shank et al., 2007)]. The rAAV-5-HT2AR-Flag
(2µl, 109–1010 transducing units/ml) or lactated ringer’s solution
vehicle control (2µl) was infused into the VTA (n= 10 per group)
using the UMP II infusion pump (WPI, Sarasota, FL, USA) at
a rate of 18 nl/min; the infusion lasted 2 h. Following infusion,
the needle was left in place for 10 min followed by withdrawal
from the brain and wound closure. Rats received a single injection
(IM) of 300,000 U of sodium ampicillin after surgery and were
allowed 1 week to recover, during which time they were handled
and weighed daily.
BEHAVIORAL PROCEDURES
Apparatus
Locomotor activity was quantified using a modified open-field
activity system under low-light conditions (San Diego Instru-
ments, San Diego, CA, USA). Each enclosure consisted of a clear
Plexiglas open-field (40 cm× 40 cm× 40 cm) and a 4× 4 pho-
tobeam matrix located 4 cm above the cage floor for the mea-
surement of horizontal activity; each monitor was housed within
sound-attenuating chambers. A second horizontal row of 16 pho-
tobeams located 16 cm from the floor allowed the measurement of
rearing. Activity counts were made by the control software (Pho-
tobeam Activity Software, San Diego Instruments, San Diego, CA,
USA) and stored for statistical evaluation. Video cameras located
above the enclosures were used to monitor activity continuously
without disruption of behavior.
Effects of 5-HT2AR overexpression on basal and cocaine-evoked
locomotor activity
On Day 7 following surgery, animals were placed in activity moni-
tors and horizontal activity and rearing were recorded for 60 min,
followed by return to the animal colony. Additionally, activity was
again measured in these same animals on Days 14 and 21 following
surgery for 60 min on each day. On Day 21, following the measure-
ment of basal locomotor activity, all animals were challenged with
15 mg/kg of cocaine [(-)-cocaine HCl salt; National Institute on
Drug Abuse, Research Triangle, NC, USA dissolved in 0.9% NaCl],
a dose that consistently produces hyperactivity in our laboratory
(McCreary and Cunningham, 1999; De La Garza and Cunning-
ham, 2000; Liu and Cunningham, 2006; Cunningham et al., 2013).
Immediately following injection, horizontal activity and rearing
were measured for 60 min.
Both horizontal activity and rearing counts were totaled for
each animal in 10-min time bins and across the 60-min test ses-
sions. All data are presented as mean horizontal activity counts or
rearing counts (±SEM). For basal locomotor activity, a two-way
ANOVA was used to analyze the effects of intra-VTA pretreatment
(control or rAAV-5-HT2AR-Flag; factor 1) and day (Days 7, 14,
21; factor 2) with pretreatment as a between-subjects factor and
day as a within-subjects factor. Planned comparisons for each test
day were made with a Student’s t -test with a Bonferroni correc-
tion. To analyze the time course of cocaine-evoked activity on Day
21, a two-way ANOVA with factors of intra-VTA pretreatment
(between-subjects) and time (within-subjects) was utilized fol-
lowed by planned comparisons at each time point using a Student’s
t -test with a Bonferroni correction. Differences in the mean total
hyperactivity observed for the 60-min period following cocaine
injection on Day 21 were analyzed with a Student’s t -test. All sta-
tistical tests were determined using SAS for Windows (Version 8.1)
with an experiment wise α= 0.05.
Histology and transgene detection
At the end of behavioral testing on Day 21, animals were
deeply anesthetized with an intraperitoneal (IP) injection of
pentobarbital (Sigma, 100 mg/kg) and transcardially perfused
with PBS followed by 3% buffered paraformaldehyde. Brains
were then removed, blocked at the mid-pons, and post-fixed in
paraformaldehyde at room temperature for 2 h. Tissue was then
cryoprotected in 30% sucrose solution at 4˚C for 48 h. Brains
were frozen with crushed dry ice and stored at −80˚C. Coronal
sections (50µm) were prepared with a Leica cryostat (CM 1850)
at −20˚C and processed to verify microinjection placement and
transgene expression using immunohistochemistry (see below).
Data obtained from rats with infusion sites outside of the VTA
were excluded from analysis.
To validate the ability of the rAAV construct to establish expres-
sion of 5-HT2AR and Flag within the VTA, we employed immuno-
histochemical techniques using diaminobenzidine detection and
light microscopy as described previously (Allen and MacPhail,
1991; Ross et al., 2006; Shank et al., 2007). Briefly, sections were
blocked with a solution containing 1.5% normal goat serum
(Vector Laboratories, Burlingame, CA, USA) in PBS with 0.4%
Triton-X (PBS-T; Sigma), followed by incubation in PBS-T con-
taining a polyclonal antibody for either the 5-HT2AR (1:1000;
courtesy of Dr. Bryan Roth, Case Western University Cleveland,
OH, USA; Garlow et al., 1993; Roth et al., 1995; Cornea-Hebert
et al., 2002; Nocjar et al., 2002; Bubar et al., 2005; Ross et al.,
2006) or Flag peptide (1:1000; Sigma). Sections were washed in
PBS, incubated in PBS-T containing biotinylated goat-anti-rabbit
IGg (1:400; Vector), incubated in an avidin-biotin-horseradish
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peroxidase complex (Vector), washed in TRIS buffer and devel-
oped in 3,3′-diaminobenzidine (0.5 mg/ml; Sigma) with 0.005%
H2O2. Sections were mounted onto slides and coverslipped, fol-
lowed by visualization with an Olympus Vanox-T AH2 microscope
and image capture using a Pixera Professional camera (VCS10132;
Sherwood Dallas, Co., Dallas, TX, USA) that was connected to a
personal computer. Images of the VTA ipsilateral and contralateral
to the injection site were captured and each image was subse-
quently cropped to a fixed-size rectangle of 420× 1238 pixels
located within the parabrachial-paranigral subnuclei of the VTA
(Phillipson, 1979; Swanson, 1982) for comparative analyses. In
accordance with recent image guidelines (Couzin, 2006), Adobe
Photoshop (Adobe Systems, San Jose, CA, USA) was employed to
mask dark shadows arising as injection artifacts on several sections.
The fixed-size images of the VTA were analyzed using a pro-
gram written in Matlab (MathWorks, Inc., Natick, MA, USA) and
the red channel of the image data was used for analysis (Hillman,
1984; Pollandt et al., 2005; Liu et al., 2007). The intensity histogram
was computed, producing a bell-shaped curve, skewed toward the
dense side by the presence of darker (stained) pixels, which occupy
a small fraction of the image area. The non-stained tissue density
was modeled by fitting a normal curve to the upper portion of the
histogram, using the Marquard non-linear least-squares method.
The fitted curve was subtracted from the observed histogram on
the dense side of the peak, providing an estimate of the intensity
distribution of staining. A threshold was selected that was 2.6 stan-
dard deviations below the mean of the fitted background curve.
Pixels darker than the threshold were considered to be stained and
were displayed as a map for visual confirmation. The number of
such pixels was counted to quantify immunolabeling (Hillman,
1984; Pollandt et al., 2005; Liu et al., 2007). Total immunola-
beling was determined as the sum of stained pixels weighted by
their density below the staining threshold and was calculated from
VTA images ipsilateral and contralateral to the infusion site. The
difference in total immunolabeling from the ipsilateral minus con-
tralateral VTA from each animal was compared between infusion
groups with an unpaired Wilcoxon test.
To explore localization of 5-HT2AR within VTA cells and co-
localization of 5-HT2AR in DA neurons, confocal microscopy
(Bubar and Cunningham, 2007; Bubar et al., 2011; Anastasio et al.,
2013) was utilized to study double-label immunofluorescence with
previously validated antibodies for the 5-HT2AR (Garlow et al.,
1993; Roth et al., 1995; Cornea-Hebert et al., 2002; Nocjar et al.,
2002; Bubar et al., 2005) and tyrosine hydroxylase (TH; Brown-
ing et al., 2005). Methods for immunofluorescence were similar to
those described above with a few minor modifications. A separate
cohort of rats (n= 7) was unilaterally infused with lactated ringer’s
solution control or rAAV-5-HT2AR-Flag (as described above) and
sacrificed 4 weeks following infusion. Sections (25µm) were pre-
pared using the Leica cryostat, followed by several washes and
incubation in blocking serum (PBS-T plus 1.5% goat serum) as
described above. Single sections were then incubated in PBS-T
containing both the 5-HT2AR antibody (1:1000) and a mono-
clonal antibody for TH (1:2500; Immunostar). Sections were then
washed in PBS and incubated in PBS-T containing secondary
fluorescent goat-anti-rabbit (1:2000; Alexa fluor 555; Invitrogen,
Carlsbad, CA, USA) and goat-anti-mouse (1:2000; Alexa fluor 488;
Invitrogen) antibodies at room temperature. Last, sections were
mounted as described above and labeling visualized at the UTMB
Infectious Disease Optical Imaging Core using a Zeiss LSM 510
Meta confocal microscope and image capture with LSM 5 imaging
software (Carl Zeiss Microimaging, Thornwood, NY, USA) that
was connected to a personal computer.
RESULTS
EFFECTS OF 5-HT2AR OVEREXPRESSION ON BASAL AND
COCAINE-EVOKED ACTIVITY
To test the hypothesis that overexpression of the 5-HT2AR in
the VTA enhances basal or cocaine-evoked hyperactivity, male
rats (n= 10/group) were pretreated with intra-VTA infusion of
either lactated Ringer’s solution (control) or rAAV-5-HT2AR-Flag
(virus). Of these, nine control rats exhibited needle placements
positioned in the VTA (see below); one animal contained a needle
placement outside of the VTA, and was thus excluded. Of virus-
pretreated animals, five exhibited proper VTA placement as well as
virally mediated overexpression of the 5-HT2AR (see below). One
virus-pretreated animal exhibited overexpression in the hypothal-
amus as a result of incorrect placement, and four animals did
not exhibit 5-HT2AR overexpression; these animals were excluded
from analysis.
Basal locomotor activity measured on Days 7, 14, and 21 was
analyzed for control animals with proper VTA placements and
virus-pretreated animals with overexpression confined to the VTA
(Figure 1). The levels of basal locomotor activity observed, regard-
less of pretreatment, were similar to levels of locomotor activity
evoked upon saline injection in previous studies (McMahon and
Cunningham, 2001; McMahon et al., 2001; Filip and Cunningham,
2002; Bubar et al., 2003). There was no main effect of pretreat-
ment (F1, 41= 0.11, p= 0.747), day (F2, 41= 3.17, p= 0.06), or a
pretreatment× day interaction (F2, 41= 3.18, p= 0.06) observed
for basal horizontal activity on Days 7, 14, and 21 after viral
injections. A priori comparisons indicated that the basal hori-
zontal activity did not differ between pretreatment groups on any
test day (Figure 1A). For basal rearing activity, a main effect of
day (F2, 41= 10.97, p= 0.0004) in the absence of a main effect
of pretreatment (F1, 41= 0.65, p= 0.435) or a pretreatment× day
interaction (F2, 41= 0.46, p= 0.638) was observed (Figure 1B);
a priori comparisons between treatment groups failed to indicate
significant differences in basal rearing activity between control
and virus treatment groups on any given test day. Levels of basal
activity in animals with misplaced rAAV-5-HT2AR-Flag infusions
outside of the VTA did not differ from control animals on days 7,
14, or 21 (data not shown; p> 0.05).
On Day 21 following the measurement of basal locomotor
activity, all animals were challenged with 15 mg/kg of cocaine
and activity was recorded for 60 min (Figure 2). A main effect
of pretreatment (F1, 83= 7.84, p= 0.016), time (F5, 83= 28.37,
p< 0.0001), and a pretreatment× time interaction (F5, 83= 28.37,
p< 0.0001) were observed for cocaine-evoked horizontal activity
measured in 10-min time bins during the 60-min test (Figure 2A,
left panel). A priori comparisons indicated that viral pretreat-
ment was associated with significantly greater cocaine-evoked
horizontal activity during each of the first two time bins (10
and 20 min) of the test period as compared to control animals
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FIGURE 1 | Basal levels of motility are unchanged following intra-VTA
infusion of rAAV-5-HT2AR-Flag. Mean total horizontal (A) or rearing activity
(B) [counts/60 min (±SEM)] were recorded 7, 14, and 21 days following
intracerebral pretreatment with 2µl of vehicle (Control; open bar; n=9) or
rAAV-5-HT2AR-Flag (Virus, filled bar; n=5). Both pretreatment groups
exhibited similar levels of horizontal and rearing activity on each day
analyzed.
(p< 0.008/comparison). A trend for increased cocaine-evoked
horizontal activity was observed but not statistically significant
at the 30 min (p= 0.04) and 40 min time bins (p= 0.04). The
a priori analysis indicated that virus pretreatment was associated
with significantly greater levels of cocaine-evoked horizontal activ-
ity totaled for the entire 60-min test session (Figure 2A, right
panel; p< 0.05). Levels of cocaine-evoked horizontal activity in
animals with misplaced rAAV-5-HT2AR-Flag infusions outside of
the VTA did not differ from control animals (data not shown;
p> 0.05).
Rearing activity was also measured following cocaine injec-
tion on Day 21. A main effect of pretreatment (F1, 83= 6.61,
p= 0.025) and a pretreatment× time interaction (F5, 83= 3.13,
p= 0.014), but not a main effect of time (F5, 83= 0.82, p= 0.538),
were observed for cocaine-evoked rearing activity measured in 10-
min time bins during the 60-min test (Figure 2B).Apriori planned
comparisons indicated that the viral pretreatment was associated
with greater cocaine-evoked rearing activity at the 50 min time bin
(p< 0.008/comparison), with the comparisons made at the 30 min
FIGURE 2 | Intra-VTA infusion of rAAV-5-HT2AR-Flag is associated with
elevated cocaine-induced motility. Data represent the mean total
horizontal (A) or rearing activity (B) in rats induced upon injection with
cocaine (15 mg/kg, ip) 21 days after a 2µl infusion of vehicle (Control; open
symbols; n=9) or rAAV-5-HT2AR-Flag (Virus; filled symbols; n=5). Left
panels represent the timecourse across the 60 min session divided into
10 min bins [mean activity counts/10 min (±SEM)]; *p<0.008 vs. control at
same time point. Right panels illustrate mean total horizontal (A) or rearing
activity (B) for the entire 60 min session [counts/60 min (±SEM); *p<0.05
vs. control. Dashed line represents average level of basal horizontal or
rearing activity determined in the 60 min period prior to cocaine injection
(see Figure 1).
(p= 0.047), 40 min (p= 0.01), and 60 min time bins (p= 0.023)
of the test period approaching statistical significance (Figure 2B,
left panel). The a priori analysis indicated that virus pretreatment
was associated with significantly greater levels of cocaine-evoked
rearing activity totaled across the entire 60-min test session com-
pared to control animals (Figure 2B, left panel; p< 0.05). Levels of
cocaine-evoked rearing activity in animals with misplaced rAAV-
5-HT2AR-Flag infusions outside of the VTA did not differ from
control animals (data not shown; p> 0.05).
5-HT2AR AND FLAG IMMUNOHISTOCHEMISTRY
Following the completion of behavioral testing on Day 21, ani-
mals were sacrificed and immunohistochemistry performed to
confirm overexpression of 5-HT2AR and expression of Flag in
the VTA (Figure 3). A representative photomicrograph depicting
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FIGURE 3 | Intra-VTA infusion of rAAV-5-HT2AR-Flag is associated with
overexpression of 5-HT2AR and Flag peptide immunolabeling. Shown are
representative photomicrographs of (A) anti-5-HT2AR antibody labeling of VTA
neurons in control animals; (B) anti-Flag antibody labeling of VTA neurons in
control animals; (C) anti-5-HT2AR antibody labeling of VTA neurons in virus
animals infused with rAAV-5-HT2AR-Flag; (D) labeling with anti-Flag antibody in
an immediately adjacent tissue section of virus-pretreated animal indicates
co-localization of 5-HT2AR and Flag. (E) Quantification of net 5-HT2AR
immunoreactivity (±SEM) in VTA of control animals (open bar; n=9) vs. virus
animals infused with rAAV-5-HT2AR-Flag-(filled bar; n=5). Animals that
previously received intra-VTA viral infusion exhibited greater 5-HT2AR
immunoreactivity than control animals, confirming viral overexpression of
5-HT2AR. (F) Quantification of net Flag immunoreactivity (±SEM) in VTA of
control animals (open bar; n=9) vs. virus animals infused with
rAAV-5-HT2AR-Flag (filled bar; n=5). Animals that previously received
intra-VTA viral infusion exhibited greater Flag immunoreactivity than those
control animals, further confirming viral overexpression of 5-HT2AR. Scale
bar=20µm. *p<0.05 vs. control.
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5-HT2AR immunolabeling in the VTA ipsilateral to the infusion
site from a control animal illustrates that the majority of the 5-
HT2AR immunoreactivity seems to be confined to cell bodies,
with little fiber labeling (Figure 3A). Control animals exhibited
little Flag background labeling (Figure 3B). In contrast, 5-HT2AR
immunolabeling in the ipsilateral VTA from a virus animal infused
with rAAV-5-HT2AR-Flag (Figure 3C) illustrates a distinct pattern
of 5-HT2AR immunolabeling characterized by robust 5-HT2AR
immunoreactivity in both cell bodies and fibers. A brain section
labeled with the anti-Flag antibody and adjacent to that shown in
Figure 3C shows a similar expression of immunoreactivity, with
labeled cell bodies as well as fibers (Figure 3D). Additionally, the
arrows indicate labeled cells in Figures 3C,D seem to be identical,
providing further evidence of successful overexpression.
A comparison of the 5-HT2AR immunoreactivity quantified
in the VTA (Figure 3E) was made using an unpaired Wilcoxon
test. Control animals exhibited similar, moderate levels of 5-
HT2AR immunoreactivity in the VTA ipsilateral (Figure 3A) and
contralateral (data not shown) to the infusion site. Infusion of
rAAV-5-HT2AR-Flag resulted in overexpression of 5-HT2AR in
the ipsilateral (Figure 3C), but not contralateral, VTA (data not
shown). The total net immunolabeling (ipsilateral immunola-
beling – contralateral immunolabeling) was then calculated in
individual animals in order to normalize 5-HT2AR overexpres-
sion to basal 5-HT2AR levels in the brain hemisphere contralateral
to viral infusion. This total net immunolabeling was then com-
pared between pretreatment groups and the results indicate that
greater levels of 5-HT2AR expression were exhibited in virus-
pretreated animals (p< 0.05; Figure 3E). Quantification of Flag
immunoreactivity with this same procedure also revealed robust
levels of Flag labeling in virus-pretreated animals, as compared
to control animals (p< 0.05; Figure 3F), further confirming suc-
cessful expression of the transgene. Levels of 5-HT2AR and Flag
immunoreactivity in animals with misplaced rAAV-5-HT2AR-Flag
infusions outside of the VTA did not differ from control animals
(data not shown; p> 0.05).
Confocal microscopy was utilized to analyze tissue sections
processed for double-labeled 5-HT2AR and TH immunoflu-
orescence in the VTA in order to assess localization of 5-
HT2AR to DA neurons (Figure 4) from animals pretreated
with vehicle (Figure 4A) or AAV-5-HT2AR-Flag (Figures 4B–F).
Figure 4A demonstrates a composite confocal image (24 sections,
0.68µm/slice) of 5-HT2AR immunoreactivity from the VTA of
a control animal. Immunolabeling is predominantly confined to
cell body regions (Figure 4A) in keeping with our observation
of 5-HT2AR staining using DAB (above; Figure 3) and previous
studies using the same anti-5-HT2AR antibody (Nocjar et al., 2002;
Bubar et al., 2005). Figure 4B demonstrates a composite confocal
image (24 sections, 0.70µm/slice) of 5-HT2AR immunoreactivity
in the VTA of an animal infused with rAAV-5-HT2AR-Flag. Over-
expression is indicated by the robust immunoreactivity in both cell
bodies and fibers (Figure 4B). Figures 4C–F represents composite
confocal images of double-label immunofluorescence from an ani-
mal infused with rAAV-5-HT2AR-Flag. Figure 4C demonstrates a
composite confocal image (24 sections, 0.71µm/slice) of 5-HT2AR
immunoreactivity in the VTA of an animal infused with AAV-5-
HT2AR-Flag, and Figure 4D demonstrates immunoreactivity for
TH in the same tissue section as that shown in Figure 4C. The
composite image represents localization of 5-HT2AR immunore-
activity in a TH-positive cell (Figure 4E). Additionally, 20 of the
serial Z -sections that comprise the composite image in Figure 4E
are shown in Figure 4F (Bubar and Cunningham, 2007; Bubar
et al., 2011; Anastasio et al., 2013).
DISCUSSION
The present study is the first to demonstrate that overexpression
of 5-HT2AR protein in the VTA enhances the behavioral effects
of cocaine following successful virally mediated overexpression of
the 5-HT2AR in the adult rat. Intra-VTA transduction with the
rAAV-5-HT2AR-Flag vector, which produced quantifiable over-
expression of 5-HT2AR and appearance of the Flag protein in
VTA neurons, had little effect on basal levels of motor activ-
ity, but significantly enhanced cocaine-evoked motility relative
to controls. These results are in line with an overall facilitatory
role for the 5-HT2AR in mediating cocaine-evoked behaviors (see,
Bubar and Cunningham, 2008; Nic Dhonnchadha and Cunning-
ham, 2008) and support the hypothesis that the VTA is a key site
of action for the 5-HT2AR to control the behavioral effects of
cocaine.
The current results revealing that overexpression of 5-HT2AR
in the VTA enhances cocaine-evoked hyperactivity are in accor-
dance with a previous study from our laboratory demonstrating
that intra-VTA microinjection of the selective 5-HT2AR antago-
nist M100907 blocked cocaine-evoked hyperactivity (McMahon
et al., 2001). These effects parallel those of systemic injection of
5-HT2AR ligands, as 5-HT2AR antagonists block and 5-HT2AR
agonists enhance the hypermotive effects of cocaine (McMahon
and Cunningham, 2001; Fletcher et al., 2002; Filip et al., 2004) and
other stimulants (Auclair et al., 2004; Herin et al., 2005). These
data implicate the VTA as a critical site of action for the posi-
tive modulatory control of 5-HT2AR over psychostimulant-evoked
motor activity. This stimulatory role for VTA 5-HT2AR upon
cocaine-evoked hypermotility appears to occur in the absence of
an apparent tonic regulatory influence of this receptor on motor
activity. Overexpression of the 5-HT2AR in the VTA has no effect
upon basal levels of motility evoked upon exposure to the activity
monitors. These data are consistent with studies in the literature
demonstrating that selective blockade of 5-HT2AR in the VTA does
not alter spontaneous locomotor behavior (McMahon et al., 2001;
Auclair et al., 2004). However, we have observed the enhancement
of motor activity upon intra-VTA infusion of the non-selective
5-HT2AR agonist DOI (Herin et al., unpublished observations).
Together, these data indicate that, despite robust enhancement of
5-HT2AR immunoreactivity in both cell bodies and fibers relative
to controls, elevated expression of the 5-HT2AR in the VTA alone
is not sufficient to induce overt alterations in basal motor acti-
vation. However, the elevated VTA 5-HT2AR expression generates
an augmented and positive modulatory effect over cocaine-evoked
hyperactivity.
Several characteristics of the 5-HT2AR may account for the
low levels of basal 5-HT2AR function. For example, the 5-HT2AR
exhibits moderate affinity for 5-HT (Peroutka, 1986; Rothman
et al., 2000; Leysen, 2004) and possesses modest constitutive
activity in the absence of ligand binding (Berg et al., 2005). In
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FIGURE 4 | Confocal microscopy demonstrates robust 5-HT2AR
labeling in theVTA and co-localization in cells immunopositive for
tyrosine hydroxylase (TH). (A) Representative composite confocal
image (24 slices, 0.68µm/slice) demonstrates 5-HT2AR
immunoreactivity (red) in VTA neurons from control animals.
(B) Representative composite confocal image (24 slices, 0.7µm/slice)
demonstrates 5-HT2AR immunoreactivity (red) in VTA neurons from
virus animals pretreated with rAAV-5-HT2AR-Flag. (C–F) Representative
composite confocal image (24 slices, 0.71µm/slice) demonstrating
co-localization of 5-HT2AR and TH in VTA neurons from virus animals
pretreated with rAAV-5-HT2AR-Flag. In the same tissue section, there is
robust 5-HT2AR immunoreactivity (C) and TH immunoreactivity (D) that
is colocalized to the same cells (E). (F) Contains 20 of the Z -sections
that make up the composite image. Scale bar=5µm.
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addition, although the 5-HT2AR is thought to primarily localize
to somata or dendrites postsynaptic to 5-HT terminals, ultra-
structural localization studies indicate that the receptor promi-
nently localizes to the cytoplasm, rather than the plasma mem-
brane, and is primarily found in extrasynaptic regions (Cornea-
Hebert et al., 1999; Doherty and Pickel, 2000). Such localiza-
tion patterns suggest that a component of 5-HT actions at the
5-HT2AR may occur via paracrine or volume transmission which
may be minimal at baseline (Miner et al., 2000; Jansson et al.,
2001). Thus, activation of the 5-HT2AR receptors in VTA may
only occur during periods of stimulated 5-HT release like that
evoked following systemic cocaine administration (Chen and
Reith, 1994).
The differential effects of 5-HT2AR antagonists delivered into
the VTA upon basal vs. cocaine-stimulated motor activity have
been attributed to their efficacy to alter the activation status of
the DA mesoaccumbens pathway to control locomotor activity
(Kelly and Iversen, 1976; Broderick et al., 2004), and are in accor-
dance with a prevailing hypothesis that the 5-HT2AR modulates
DA mesocorticoaccumbens neurotransmission only under “stim-
ulated” conditions (Schmidt et al., 1992; De Deurwaerdere and
Spampinato, 1999; Di Giovanni et al., 1999; Bonaccorso et al.,
2002; Kuroki et al., 2003; Auclair et al., 2004). In accordance with
the lack of effects of intra-VTA administration of 5-HT2AR antag-
onists on basal levels of motor activation (McMahon et al., 2001;
Auclair et al., 2004), local infusion of 5-HT2AR antagonists into the
VTA failed to alter basal DA release in the NAc (Auclair et al., 2004),
nor did perfusion of 5-HT2AR antagonists alter firing rates of VTA
DA neurons in a midbrain slice preparation (Olijslagers et al.,
2004). Conversely, intra-VTA 5-HT2AR antagonist administration
significantly blocked systemic cocaine- (McMahon et al., 2001)
and amphetamine-evoked hypermotility (Auclair et al., 2004) and
associated amphetamine-evoked NAc DA release (Auclair et al.,
2004). Thus the selective effects of VTA 5-HT2AR overexpres-
sion upon cocaine-evoked as opposed to basal motor activity are
likely due to 5-HT2AR-mediated facilitation of DA mesoaccum-
bens neurotransmission under stimulated vs. tonic conditions,
respectively.
The 5-HT2AR is natively resident within DA and non-DAergic
(GABA- or possibly glutamate-containing) neurons in the VTA
(Doherty and Pickel, 2000; Ikemoto et al., 2000; Nocjar et al.,
2002; Yamaguchi et al., 2007) although DA neurons comprise
the majority of VTA neuronal cells (Swanson, 1982; Johnson and
North, 1992; Ikemoto, 2007). Indeed, our confocal immunoflu-
orescence studies (see Figure 4) provide evidence of 5-HT2AR
overexpression in VTA DA neurons. Activation of elevated lev-
els of 5-HT2AR resident in DA neurons consequent to cocaine-
evoked elevations in 5-HT efflux (Chen and Reith, 1994) would
be expected to increase activity of DA neurons (Pessia et al.,
1994) and release of DA in terminal regions (De Deurwaerdere
and Spampinato, 1999). As noted above, enhanced DA release
in the NAc correlates positively with generation of hypermotil-
ity (Kelly and Iversen, 1976). Thus, overexpression of 5-HT2AR
within DA neurons that project to the NAc would serve to enhance
cocaine-evoked hyperactivity, as was observed in the present study.
Although the overexpression of 5-HT2AR in the DA neurons aligns
with the observed behavioral profile, 5-HT2AR overexpression also
likely occurred in non-DAergic VTA neurons, presumably GABA
interneurons and/or projection neurons, or possibly glutamate
neurons (Yamaguchi et al., 2007; see Figure 4), since the con-
stitutively active promoter utilized evokes gene expression in all
neuronal cell types (Kaplitt et al., 2007; St Martin et al., 2007).
Future studies employing a promotor that would direct viral
expression to either DA, GABA, or glutamate neurons would help
to discern the contribution of 5-HT2AR overexpression within the
particular neuronal cell type to basal vs. cocaine-evoked locomotor
activity.
The behavioral phenotype observed following rAAV-5-HT2AR-
Flag infusion is most likely mediated by neurons intrinsic to
the VTA. Measurable 5-HT2AR overexpression was confined to
the site of infusion, and adjacent brain regions (especially, sub-
stantia nigra; data not shown) did not demonstrate patterns of
5-HT2AR overexpression. Second, in keeping with this observa-
tion, cells projecting to the VTA were not likely to be transduced,
as the virus utilized in these studies (AAV-2) is not readily trans-
ported retrogradely following infusion into the brain (Chamber-
lin et al., 1998). Third, the cells transduced in the VTA fit the
morphological profile suggestive of neurons, consistent with pre-
vious observations that AAV-2 does not readily transduce glial
cells (Chamberlin et al., 1998). Fourth, while theoretically possi-
ble that viral vector transduction per se could evoke behaviorally
relevant cellular changes, this possibility is highly unlikely. Previ-
ous studies have shown that transduction of neural tissue with
AAV vectors does not alter the electrophysiological properties
of neurons (Ehrengruber et al., 2001) or result in neurotoxicity
(Lo et al., 1999), while animals infused intracranially with either
vehicle or control viral vectors (Carlezon Jr. et al., 1997; Pliakas
et al., 2001), including AAV (Landgraf et al., 2003), exhibit equally
normal patterns of behavior. Basal locomotor activity did not
differ between the animals infused with control vs. AAV in the
present study, and the levels of activity observed were similar to
that reported in previous studies following saline injection stud-
ies (McMahon and Cunningham, 2001; McMahon et al., 2001;
Filip and Cunningham, 2002; Bubar et al., 2003). Finally, ani-
mals with rAAV-5-HT2AR-Flag infusions located outside the VTA
exhibited levels of cocaine-evoked hyperactivity similar to that of
control animals. Altogether, these data point to the overexpres-
sion of 5-HT2AR in the VTA as the most likely contributor to the
observed enhancement of cocaine-evoked hyperactivity following
rAAV-5-HT2AR-Flag infusion.
The results of present study suggest that expression levels of
the 5-HT2AR in the VTA regulate vulnerability to the hyper-
motive effects of cocaine and support a possible role for VTA
5-HT2AR in modulating other behavioral effects of cocaine medi-
ated by DA mesocorticoaccumbens circuitry. In addition to alter-
ing cocaine-evoked hyperactivity, systemic administration of 5-
HT2AR antagonists has been shown to reduce the discriminative
stimulus effects of cocaine (McMahon and Cunningham, 2001;
Filip et al., 2006) and cocaine-evoked behavioral disinhibition (i.e.,
impulsivity; Anastasio et al., 2011; Fletcher et al., 2011), as well
as to block expression of cocaine sensitization (Filip et al., 2004;
Zayara et al., 2011). Furthermore, although the 5-HT2AR does not
appear to modulate cocaine intake in the self-administration assay
(Fletcher et al., 2002; Nic Dhonnchadha et al., 2009), 5-HT2AR
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antagonists have been shown to attenuate both cocaine- and cue-
evoked reinstatement of cocaine-seeking (Fletcher et al., 2002; Nic
Dhonnchadha et al., 2009). However, no studies have evaluated
specifically the role of VTA 5-HT2AR receptors in cocaine-evoked
behaviors other than locomotor hyperactivity (McMahon et al.,
2001), though 5-HT2AR in the NAc (Zayara et al., 2011) and PFC
(Pockros et al., 2011) have been implicated in sensitization and
cue-evoked reinstatement of cocaine-seeking, respectively. Here
we employed a single, low dose of cocaine (15 mg/kg) that con-
sistently induces hypermotility in the absence of overt stereotypic
behaviors (Herges and Taylor, 1998) to further establish a criti-
cal role for VTA 5-HT2AR in the hypermotive effects of cocaine.
Even with the small sample size employed in the current study,
the behavioral response to the single dose of cocaine produced a
robust behavioral response with little variability. Our results com-
bined with the knowledge regarding 5-HT2AR regulation of DA
mesocorticoaccumbens activation provide the impetus to conduct
more thorough investigations into the role of 5-HT2AR regulation
in the VTA not only in the hypermotive effects of cocaine, but
also more complex cocaine-associated behaviors. Furthermore,
the methods established here utilizing rAAV-5-HT2AR-Flag to
overexpress the 5-HT2AR can be employed to evaluate the role
of elevated 5-HT2AR expression throughout the brain.
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